However, inclusive of the factors you mentioned in tandem with other options mentioned in the report this is just the early stages of both dosage strength and appraisal of dual clinical applications the company is developing.
However, inclusive of the factors you mentioned in tandem with...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(2.83%) |
Mkt cap ! $383.0M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.1¢ | $823.4K | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 5629286 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 2676195 | 21 |
View Market Depth
| Last trade - 13.54pm 12/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |